|
Real-time Estimate
Cboe BZX
11:12:23 2026-08-27 am EDT
|
5-day change | 1st Jan Change | ||
| 26.92 USD | +3.44% |
|
+2.81% | +51.64% |
| Aug. 25 | Zai Lab's Net Loss Widens 14% in H1, Revenue Drops 6% | MT |
| Aug. 25 | Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.92B | - | ||||
| 81.36B | |||||
| 59.75B | - | ||||
| 59.19B | |||||
| 53.33B | |||||
| 49.09B |
- Stock Market
- Stocks
- ZLAB Stock
- Charts Zai Lab Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
